FACULTY
G. Wayne Raborn, DDS, MS
Professor Emeritus, Dentistry
University
of Alberta
Edmonton,
AB, Canada
FINANCIAL
DISCLOSURE
G. Wayne Raborn reports of serving as a consultant for Morrison & Foerster,
LLC.
ACCREDITATION
STATEMENTS
Pharmacists
Postgraduate Healthcare Education, LLC is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
Program
No.: 430-000-06-046-H01
Credits:
2.0 hours (.20 ceu)
Exam processing inquiries and booklet orders to:
CE
Customer Service Manager (800) 825-4696
Direct educational content inquiries to:
CE
Director (800) 331-9396
TARGET AUDIENCE
This
accredited program is targeted to pharmacists and pharmacy technicians.
Estimated time to complete this monograph and posttest is 90 to 120 minutes.
PROCEDURES
To receive credit and your exam score, please complete the exam questions and
program evaluation on the answer card. Indicate your profession. For fastest
service, enter your answers on the Internet at www.powerpak.com (Courses and
Answer Sheets), or fax or mail to:
Power-Pak C.E.TM
PO Box 541 Canal Street Station
New York,
NY 10013
Fax: (212)
219-7849
GOAL
The goal of this program is to educate pharmacists on the pharmacodynamic
considerations in the selection of a product for the treatment of cold sores,
with emphasis on cell entry inhibitors, antivirals, and palliative care
products.
EDUCATIONAL
OBJECTIVES
At the conclusion of this program, participants will be able to:
-
Discuss the pathophysiology and symptomatology
associated with cold sores
-
Review the current three categories of products to
treat cold sores (cell entry inhibitors, antivirals, and palliative
treatments), with emphasis on their mechanism of action
-
Describe the role of the pharmacist in assisting
patients with selection of an OTC product for the treatment of cold sores,
with emphasis on inhibition of viral replication
-
Discuss strategies pharmacists may employ to
educate and counsel patients about managing cold sore outbreaks
Disclosure of
Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty
and do not necessarily represent the views of Power-Pak C.E. and
GlaxoSmithKline Consumer Healthcare.
Participants have
an implied responsibility to use the newly acquired information to enhance
patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient
management. Any procedures, medications, or other courses of diagnosis or
treatment discussed or suggested in this activity should not be used by
clinicians without evaluation of their patients' conditions and possible
contraindications on dangers in use, review of any applicable manufacturer's
product information, and comparison with recommendations of other authorities.
The author,
sponsor, and publisher of this continuing education program have made all
reasonable efforts to ensure that all information contained herein is accurate
in accordance with the latest available scientific knowledge at the time of
acceptance for publication. However, because information regarding drugs
(their administration, dosages, contraindications, adverse reactions,
interactions, special warnings, precautions, etc.) is subject to constant
change, the reader is advised to check the manufacturer's package insert for
information concerning recommended dosages and potential problems and cautions
prior to dispensing or administering the drug. Special precautions should be
taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser
or administrant. This educational activity may contain discussion of published
and/or investigational uses of agents that are not approved by the US Food and
Drug Administration (FDA). Neither the publisher nor sponsor promotes the use
of any agent outside of approved labeling. Statements made in this monograph
have not been evaluated by the FDA. Nutritional products discussed are not
intended for the diagnosis, treatment, cure, or prevention of any disease.
